As we reported earlier, Myron Wentz, founder of USANA Health Sciences, will be stepping down to focus on his role as Chairman of the board and his son Dave, formerly President of the company will now assume to role of CEO.
In some other management changes, Gil Fuller, Executive VP and CEO has decided to retire. Effective September 1st, he will step down from his management position but will continue to be engaged with the company as a strategic advisor. Jeff Yates, who is currently the VP of finance, will serve as the new CFO.
There were some other management changes made including:
- Dr. Fred Cooper, Ph.D., previously executive vice president of operations, is promoted to president and chief operating officer.
- Mark Wilson, previously executive vice president of customer relations, is promoted to executive vice president of North America.
- Kevin Guest, previously executive vice president of marketing, is promoted to chief marketing officer.
- Deborah Woo, previously vice president with responsibility for operations in Japan, South Korea, Hong Kong, and Taiwan, is promoted to executive vice president of Asia.
- Jim Bramble, USANA’s general counsel, takes on the added role of corporate secretary.
- Roy Truett, previously vice president of information technology, is promoted to chief information officer.
“I’m pleased to announce today’s promotions,” said Dr. Myron Wentz, Chairman of the Board of Directors, USANA Health Sciences. “Every one of these individuals is highly qualified to fill their new roles and will continue to help USANA achieve its long-term growth potential
No word yet on why all the sudden changes or if they had anything to do with the mixed numbers released as second quarter results or the failure of the company to take it private. Maybe Wentz has decided to shake things up now and re-group in an effort to perhaps try to take the company private again at a later date.
Popularity: 5% [?]
